Untitled
Treatment sequencing in multiple sclerosis: The benefits of disease-modifying therapies - touchNEUROLOGY
Disease-activity-free status in patients with relapsing–remitting multiple sclerosis treated with daclizumab high-yield proces
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis | NEJM
Multiple Sclerosis dataBase Independent predictors of time to relapse after CIS in high-risk patients Tim Spelman 1*, Claire Meyniel 1,2*, Maria Trojano. - ppt download
Clinical Advances in MS: Changing the Future for Patients
New insights into the burden and costs of multiple sclerosis in Europe: Results of the Czech Republic - Eva Havrdova, Gisela Kobelt, Jenny Berg, Daniela Capsa, Mia Gannedahl, Tomáš Doležal, , The
Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis
Eva K. Havrdová: Nové trendy v léčbě RS | RS kompas
Multiple sclerosis today: Disease monitoring, biomarkers and family planning - touchNEUROLOGY
Eva HAVRDOVA | Charles University in Prague, Prague | CUNI | Department of Neurology (2. LF) | Research profile
Eva HAVRDOVA | Charles University in Prague, Prague | CUNI | Department of Neurology (2. LF) | Research profile
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis–related Hospitalizations_ Integrated Analysis of the Delayed
Multiple Sclerosis dataBase Independent predictors of time to relapse after CIS in high-risk patients Tim Spelman 1*, Claire Meyniel 1,2*, Maria Trojano. - ppt download
Eva Kubala Havrdová - Proč nepodléhat strachu | RS kompas
Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: Yes
Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study | PLOS ONE
Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ | PLOS ONE
Polska Platforma Medyczna Polish Platform of Medical Research https://ppm.edu.pl Repozytorium Śląskiego Uniwersytetu Medyczneg
Eva HAVRDOVA | Charles University in Prague, Prague | CUNI | Department of Neurology (2. LF) | Research profile
MUDr. Havrdová: Nová kritéria diagnostiky RS | RS kompas
New insights into the burden and costs of multiple sclerosis in Europe: Results of the Czech Republic - Eva Havrdova, Gisela Kobelt, Jenny Berg, Daniela Capsa, Mia Gannedahl, Tomáš Doležal, , The
